Literature DB >> 12975465

HATs off to Hop: recruitment of a class I histone deacetylase incriminates a novel transcriptional pathway that opposes cardiac hypertrophy.

Yasuo Hamamori1, Michael D Schneider.   

Abstract

Histone acetylation, regulated by two antagonistic enzymes - histone acetyltransferases (HATs) and histone deacetylases (HDACs) - results in transcriptional changes and also plays a critical role in cardiac development and disease. A new study shows that overexpression of the atypical transcriptional corepressor homeodomain-only protein (Hop) causes cardiac hypertrophy via recruitment of a class I HDAC. In contrast to the body of work on transcriptional mechanisms that drive cardiac hypertrophy, including class II HDACs, this report elucidates a novel growth-suppressing transcriptional pathway in cardiac muscle that opposes hypertrophic growth.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12975465      PMCID: PMC193677          DOI: 10.1172/JCI19834

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Still stressed out but doing fine: normalization of wall stress is superfluous to maintaining cardiac function in chronic pressure overload.

Authors:  Motoaki Sano; Michael D Schneider
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

Review 2.  The diverse functions of histone acetyltransferase complexes.

Authors:  Michael J Carrozza; Rhea T Utley; Jerry L Workman; Jacques Côté
Journal:  Trends Genet       Date:  2003-06       Impact factor: 11.639

3.  Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity.

Authors:  Sudhakar Baluchamy; Hasan N Rajabi; Rama Thimmapaya; Arunasalam Navaraj; Bayar Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

Review 4.  Heterochromatin and epigenetic control of gene expression.

Authors:  Shiv I S Grewal; Danesh Moazed
Journal:  Science       Date:  2003-08-08       Impact factor: 47.728

Review 5.  Sizing up the heart: development redux in disease.

Authors:  Eric N Olson; Michael D Schneider
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

6.  Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.

Authors:  T P Yao; S P Oh; M Fuchs; N D Zhou; L E Ch'ng; D Newsome; R T Bronson; E Li; D M Livingston; R Eckner
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

Review 7.  Histone deacetylase inhibitors as new cancer drugs.

Authors:  P A Marks; V M Richon; R Breslow; R A Rifkind
Journal:  Curr Opin Oncol       Date:  2001-11       Impact factor: 3.645

8.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.

Authors:  S Imai; C M Armstrong; M Kaeberlein; L Guarente
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

9.  Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop.

Authors:  Hyun Kook; John J Lepore; Aaron D Gitler; Min Min Lu; Wendy Wing-Man Yung; Joel Mackay; Rong Zhou; Victor Ferrari; Peter Gruber; Jonathan A Epstein
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors.

Authors:  Christopher L Antos; Timothy A McKinsey; Matthew Dreitz; Lisa M Hollingsworth; Chun-Li Zhang; Kathy Schreiber; Hansjorg Rindt; Richard J Gorczynski; Eric N Olson
Journal:  J Biol Chem       Date:  2003-05-20       Impact factor: 5.157

View more
  9 in total

Review 1.  Hold me tight: Role of the heat shock protein family of chaperones in cardiac disease.

Authors:  Monte S Willis; Cam Patterson
Journal:  Circulation       Date:  2010-10-26       Impact factor: 29.690

2.  Peripherally Induced Tolerance Depends on Peripheral Regulatory T Cells That Require Hopx To Inhibit Intrinsic IL-2 Expression.

Authors:  Andrew Jones; Adeleye Opejin; Jacob G Henderson; Cindy Gross; Rajan Jain; Jonathan A Epstein; Richard A Flavell; Daniel Hawiger
Journal:  J Immunol       Date:  2015-07-13       Impact factor: 5.422

Review 3.  Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.

Authors:  Hae Jin Kee; Hyun Kook
Journal:  J Biomed Biotechnol       Date:  2010-11-29

Review 4.  Mechanisms of transcription factor acetylation and consequences in hearts.

Authors:  Devi Thiagarajan; Srinivasan Vedantham; Radha Ananthakrishnan; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  Biochim Biophys Acta       Date:  2016-08-17

Review 5.  The role of sirtuins in cardiac disease.

Authors:  Shouji Matsushima; Junichi Sadoshima
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

6.  Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development.

Authors:  Shurong Chang; Timothy A McKinsey; Chun Li Zhang; James A Richardson; Joseph A Hill; Eric N Olson
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 7.  Molecular mechanisms of diabetic cardiomyopathy.

Authors:  Heiko Bugger; E Dale Abel
Journal:  Diabetologia       Date:  2014-01-30       Impact factor: 10.122

8.  A new (heat) shocking player in cardiac hypertrophy.

Authors:  Thomas M Vondriska; Yibin Wang
Journal:  Circ Res       Date:  2008-11-21       Impact factor: 17.367

9.  MLL histone methylases regulate expression of HDLR-SR-B1 in presence of estrogen and control plasma cholesterol in vivo.

Authors:  Khairul I Ansari; Sahba Kasiri; Imran Hussain; Samara A Morris Bobzean; Linda I Perrotti; Subhrangsu S Mandal
Journal:  Mol Endocrinol       Date:  2012-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.